Hope for HIV Patients as Cytodyn Inc. (CYDY) Therapy Proves Efficacy during Clinical Trials
PRO 140, an innovative new therapy for HIV patients developed by Cytodyn Inc. (OTCQB: CYDY), is currently undergoing phase 3…
Blog
Singlepoint, Inc. (SING) Maintaining a Positive Outlook on the Future of Marijuana Sales Processing
Despite California still looking to Trump to address marijuana industry banking challenges, Singlepoint, Inc. (OTC: SING) is maintaining a positive…
Monaker Group, Inc. (MKGI) Making Travel Planning Easier Through Its Flagship NextTrip.com
According to 4Hoteliers (http://dtn.fm/zOeA9), 85% of travelers across the world are also smartphone users. The article goes on to state…
eXp World Holdings, Inc. (EXPI) Maintaining a Positive Outlook for the Real Estate Industry in the U.S.
eXp World Holdings, Inc. (OTCQB: EXPI), the holding company for the agent-owned cloud-brokerage eXp Realty LLC, is maintaining a positive…
eXp World Holdings, Inc. (EXPI) Announces eXp Realty’s Reception of the Oklahoma 2016 Top Workplaces Award
In a news release issued late Monday, eXp World Holdings, Inc. (OTCQB: EXPI) announced that eXp Realty, the company’s full-service…
MediWound Ltd. (MDWD) Receives Consensus Analysts Rating of ‘Buy’
MediWound Ltd. (NASDAQ: MDWD) is a biopharmaceutical company in the business of developing, manufacturing, and globally commercializing products that treat…
Globus Medical, Inc. (GMED) Class A Stock Sees Significant Volume Spike Moving Into 2017
As an eventful year for Globus Medical, Inc. (NYSE: GMED) is nearing an end, the leading medical device company experienced…
New to Investing? Get Started at QualityStocks!
Investing in publicly traded companies is much easier than what it used to be. Now you can sign up for…
Intellipharmaceutics International, Inc. (IPCI) Receives Aegis Update
Intellipharmaceutics International, Inc. (NASDAQ: IPCI) is a pharmaceutical company in the business of researching, developing, and manufacturing new and generic…
Revance Therapeutics, Inc. (RVNC) is “One to Watch”
Revance Therapeutics, Inc. (NASDAQ: RVNC), a biotechnology company focused on the development, commercialization, and manufacture of botulinum toxin products for…